Progress.
http://www.salon.com/2013/08/17/science_for_stoners_heres_how_pot_works/
Controlling the “learned” mental response or behavior is a foundational aspect of the seizure management mindset in western medicine. The scientific points made in the article line up with the accepted strategy to use pharmaceuticals as inhibitors to stave off what could become a “conditioned response” that develops a propensity to have seizures.
The thinking behind using inhibitors (*anticonvulsants like Keppra, Phenobarbital…) was described to Barb and I in simple terms, that the more a person has seizures, the more likely they are to have additional seizures, it becomes a learned behavior over time.
*Levetiracetam is an anticonvulsant medication used to treat epilepsy. It is the S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam. Levetiracetam is marketed under the trade name Keppra. Keppra is manufactured by UCB Pharmaceuticals Inc. Since November 2008 the drug has been available as a generic brand in the United States.
*Phenobarbital is a barbiturate, nonselective central nervous system depressant which is primarily used as a sedative hypnotic and also as an anticonvulsant in subhypnotic doses.